Market revenue in 2023 | USD 289.0 million |
Market revenue in 2030 | USD 525.6 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Oem modules |
Fastest growing segment | OEM Modules |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OEM Modules |
Key market players worldwide | Masimo Corp, Smiths Group PLC, Welch Allyn, Koninklijke Philips NV, Medtronic PLC, Nonin Medical, Nihon Kohden Corp, BD, DiaMedica Therapeutics Inc, ZOLL Medical Corporation, GE HealthCare Technologies Inc Common Stock, Hamilton Thorne Ltd, Hamilton Lane Inc Class A, Mindray Medical International, Schiller Healthcare, Avante Animal Health, Ekso Bionics Holdings Inc, BPL Medical Technologies, Burtons Medical Equipment, Criticare Technologies, Edan Instruments |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to capnography devices market will help companies and investors design strategic landscapes.
Oem modules was the largest segment with a revenue share of 42.87% in 2023. Horizon Databook has segmented the North America capnography devices market based on oem modules covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the overall market as of 2020 owing to the high demand for respiratory monitoring devices in the U.S. to manage COVID-19 patients. According to CDC (2019), pulmonary diseases, such as COPD, were the most common causes of death in the U.S.
Moreover, over 140,000 people die due to COPD every year in the U.S. As a result, regulatory authorities in the region are consistently striving to develop safe & highly efficient monitoring devices, such as capnographs, and have made their incorporation mandatory in sedation procedures.
Furthermore, according to WHO, the global population aged 60 and above is expected to increase and reach 2 billion by 2050. The market is anticipated to be primarily driven by presence of large geriatric population, which is more susceptible to respiratory diseases such as COPD and asthma. Furthermore, the risk of developing sleep apnea increases with age.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America capnography devices market , including forecasts for subscribers. This continent databook contains high-level insights into North America capnography devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account